Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 2500.00 | 1529.25 | 1947.00 | 3622.50 | 0.5375 | 0.2142 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3792.00 | 3622.50 | 1.0468 | 1.0749 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3615.00 | 3622.50 | 0.9979 | 0.9967 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 2500.00 | 1529.25 | 3950.00 | 3622.50 | 1.0904 | 1.1441 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3876.00 | 3622.50 | 1.0700 | 1.1117 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 2500.00 | 1529.25 | 2185.00 | 3622.50 | 0.6032 | 0.3322 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 2500.00 | 1529.25 | 3794.00 | 3622.50 | 1.0473 | 1.0758 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 2500.00 | 1529.25 | 1584.00 | 3622.50 | 0.4373 | 0.0287 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3623.00 | 3622.50 | 1.0001 | 1.0002 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3574.00 | 3622.50 | 0.9866 | 0.9785 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3466.00 | 3622.50 | 0.9568 | 0.9303 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3400.00 | 3622.50 | 0.9386 | 0.9007 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 2500.00 | 1529.25 | 2171.00 | 3622.50 | 0.5993 | 0.3253 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 2500.00 | 1529.25 | 3693.00 | 3622.50 | 1.0195 | 1.0312 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 4204.00 | 3622.50 | 1.1605 | 1.2542 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 2500.00 | 1529.25 | 1615.00 | 3622.50 | 0.4458 | 0.0448 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 3855.00 | 3622.50 | 1.0642 | 1.1025 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 3906.00 | 3622.50 | 1.0783 | 1.1249 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 2500.00 | 1529.25 | 4071.00 | 3622.50 | 1.1238 | 1.1967 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 2500.00 | 1529.25 | 3975.00 | 3622.50 | 1.0973 | 1.1550 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 2500.00 | 1529.25 | 3749.00 | 3622.50 | 1.0349 | 1.0559 |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3618.00 | 3622.50 | 0.9988 | 0.9980 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 4142.00 | 3622.50 | 1.1434 | 1.2275 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3781.00 | 3622.50 | 1.0438 | 1.0700 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 2500.00 | 1529.25 | 3391.00 | 3622.50 | 0.9361 | 0.8966 |